期刊文献+

组织基质金属蛋白酶抑制剂-1与尿毒症血管中膜钙化 被引量:3

MMP-9 and TIMP-1 are associated with vascular medial calcification in uremic patients
下载PDF
导出
摘要 目的研究终末期尿毒症患者桡动脉血管壁上基质金属蛋白酶及其抑制剂表达与钙盐沉积的关系,探讨基质金属蛋白酶及其抑制剂是否参与血管钙化。方法选择大连医科大学附属第一医院肾内科80例尿毒症患者的桡动脉为尿毒症组;10例因上肢外伤行截肢手术时取得桡动脉为正常对照组。HE染色观察血管;应用von Kossa染色判断钙盐沉积程度;应用免疫组化方法测定uMP-9、TIMP-1、骨桥蛋白(OPN)、I型胶原、核心结合因子(Cbfa1)在血管壁上的表达;同时测定外周血中钙、磷、三酰甘油(TG)、总胆固醇(Tch)、低密度脂蛋白(LDL)、白蛋白(ALB)、血红蛋白(Hb)、甲状旁腺激素(iPTH)、C反应蛋白(CRP)。结果80例尿毒症桡动脉血管标本中出现血管钙化36例,发生率45%;其中轻中度钙化25例,重度钙化11例,钙化均发生在血管中膜。钙化的血管中膜均有MMP-9、TIMP-1、OPN、I型胶原、Cbfa1的阳性表达(P<0.01),无钙化的44例血管中有33例血管中膜有OPN的表达,29例有I型胶原的表达,但无Cbfa1的阳性表达。对照组血管均无中膜钙化表现,亦无OPN表达。两组患者的体重指数、血钙、三酰甘油(TG)、总胆固醇(Tch)、低密度脂蛋白(LDL)、白蛋白(ALB)差异无统计学意义。尿毒症患者的平均收缩压、血磷水平、钙磷乘积、iPTH、C反应蛋白水平明显高于对照组(P<0.01)。血红蛋白水平明显低于对照组(P<0.01)。结论尿毒症患者普遍存在血管钙化,uMP-9、TIMP-1在尿毒症患者桡动脉的血管壁表达和血管钙化程度相关,提示组织基质金属蛋白酶系统在尿毒症血管钙化中可能有重要作用。 Objective To study the relationship between the medial calcification of arteries and the expressions of matrix metallopeptidase 9 (MMP-9) and tissue inhibitor of metalloproteinase 1 (TIMP-1) in uremic patients. Methods Pieces of radial arteries were taken from 80 uremic patients at the time of arteriovenous fistula operation. The control radial arteries were taken from trauma patients with normal kidney function at the time of amputation operation. Vascular calcification was evaluated histomorphometrically on Von Kossa-stained sections, and the expressions of MMP-9, TIMP-1, osteopontin (OPN), collagen I, core binding factor a-1 (Cbfa-1) were determined immunohistochemically. Other related factors including serum calcium, phosphate, cholesterol, triglyceride (TG), lowdensity lipoproteins (LDL), albumin (ALB), hemoglobin (Hb), intact parathyroid hormone (iPTH) and C-reactive protein (CRP) were also detected. Results Vascular calcification was found in 36 uremic patients (45%), while no vascular calcification in the control group. Mild to moderate calcification was found in 25 uremic patients, and severe calcification in 11 cases. All of the radial arteries with calcification showed positive immunostaining of MMP-9, TIMP- 1, OPN, collagen I and Cbfal (p〈0.01). In some uremic radial arteries without morphologically obvious calcification, immunostaining of OPN and collagen I were also positive, but immunostaining of Cbfal was negative. Mean arterial blood pressure, serum phosphate, serum calcium-phosphate product, serum iPTH and CRP were significantly higher in uremic patients than in controls (p 〈 0.01), but body mass index, serum calcium, TG, total cholesterol, LDL and ALB had no differences between the two groups. Conclusion We have demonstrated, for the first time, that expressions of MMP-9 and TIMP-1 in arteries are correlated to vascular calcification in uremic patients. Our results suggest that the imbalance expression of MMP-9/TIMP-1 may cause, at least partially, vascular medial calcification in uremic patients.
出处 《中国血液净化》 2008年第8期420-423,共4页 Chinese Journal of Blood Purification
基金 国家自然科学基金资助项目(30470805) 2005年教育部新世纪优秀人才支持计划辽宁省临床重点专科项目
关键词 尿毒症 桡动脉 血管钙化 组织基质金属蛋白酶抑制剂-1 Uremia Radial arteries Vascular calcification Matrix metallo-proteinase inhibitor-1
  • 相关文献

参考文献9

  • 1Muntner P, Coresh J, Klag MJ, et al. History of myocardial infarction and stroke among incident end-stage renal disease cases and population based controls: an analysis of shared risk factors[J]. Am J Kidney Dis, 2002, 40:23-30.
  • 2Moe SM, O'Neill KD, Duan D, et al. Medial artery calcification in ESRD patients is associated with deposition of bone matrix proteins[J]. Kidney Int, 2002,61:638-647.
  • 3Block GA: Prevalence and clinical consequences of elevated Ca X P product in hemodialysis patients[J]. Clin Nephrol, 2000,54:318-324.
  • 4Giachelli CM:Ectopic caleification:Gathering hard facts about soft tissue minteralization[J]. Am J Pathol 154:671- 675,1999.
  • 5Lijnen HR: Role of the fibrinolytic and matrix metalloproteinase systems in arterial neointima formation after vascular injury[J]. Verh K Acad Geneeskd Belg, 2001, 63:605-22.
  • 6Noji Y, Kajinami K, Kawashiri M A, et al. Circulating matrix metalloproteinases and their inhibitiors in premature coronary atherosclerosis[J]. Clin Chem Lab Med, 2001,39:380-384.
  • 7Inokubo Y, Hanada H, Ishizaka H. et al. Plasma levels of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-i are increased in the coronary circulation in patients with acute coronary syndrome[J]. Am Heart J, 2001, 141:211-217.
  • 8Lijnen HR, Soloway P, Collen D Tissue inhibitor of matrix metalloproteinases-1 impairs arterial neointima formation after vascular injury in mice[J]. Circ Res, 1999,85:1186- 91.
  • 9Pawlak K, PawlakD, Mysliwiec M. Circulating beta-chemokines and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system in hemodialyzed patients role of oxidative stress[J]. Cytokine, 2005, 31:18 24.

同被引文献26

  • 1张萍,陈江华,蒋华,王慧萍,金娟.尿毒症患者血管中膜钙化和骨特异性蛋白的表达[J].中华肾脏病杂志,2005,21(2):69-71. 被引量:11
  • 2孙艳玲,林洪丽,吴泰华,王楠,谢华,刘越坚.ERK1/2 MAPK通路在TIMP-1抑制高糖诱导的大鼠肾小球系膜细胞凋亡中的作用[J].中华肾脏病杂志,2006,22(9):554-558. 被引量:8
  • 3Derici U, El Nahas AM. Vascular calcifications in uremia: old concepts and new insights. Semin Dial, 2006, 19: 60- 68.
  • 4Moe SM, O'Neill KD, Duan D, et al. Medial artery calcifieation in ESRD patients is associated with deposition of bone matrix proteins. Kidney Int, 2002, 61: 638-647.
  • 5Vattikuti R, Towler DA. Osteogenic regulation of vascular calcification: an early perspective. Am J Physiol Endocrinol Metab, 2004. 286: E686-E696.
  • 6Lin H, Chen X, Wang J, et al. Inhibition of apoptosis in rat mesangial cells by tissue inhibitor of metalloproteinase-1. Kidney Int, 2002, 62: 60-69.
  • 7Cozzolino M, Staniforth ME, Liapis H, et al. Sevelamer hydrochloride attenuates kidney and cardiovascular calcifications in long-term experimental uremia. Kidney Int, 2003, 64: 1653-1661.
  • 8Tamagaki K, Yuan Q, Ohkawa H, et al. Severe hyperparathyroidism with bone abnormalities and metastatic calcification in rats with adenine-induced uraemia. Nephrol Dial Transplant, 2006, 21: 651-659.
  • 9Yokozawa T, Oura H, Ienaga K, et al. Comparison of renal effects of creatinine, creatol and methylguanidine in rats with adenine-induced chronic renal failure. Nephron, 1993, 64: 424-428.
  • 10Hayden MR, Tyagi SC, Kolb L, et al. Vascular ossification- calcification in metabolic syndrome, type 2 diabetes mellitus, chronic kidney disease, and calciphylaxis-calcific uremic arteriolopathy: the emerging the of sodium thiosulfate. Cardiovasc Diabetol, 2005, 4: 4.

引证文献3

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部